DIS is pleased to announce that our Covington and Slidell, LA facilities passed all inspections by the Food and Drug Administration (FDA). Twenty years ago, the Food and Drug Administration (FDA) staff helped create an environment where nearly all mammography facilities operate according to national standards, free from major inspection violations. These standards have also helped optimize radiation doses, and … Read More
Pfizer’s breast cancer drug approved two months early by FDA
Diagnostic Imaging Services shares a news story regarding early approval by the Food & Drug Administration (FDA) for promising breast cancer drug. Pfizer Inc.’s drug Ibrance was approved for advanced breast cancer by U.S. regulators more than two months ahead of schedule, letting the drugmaker proceed with one of its most promising new blockbusters. Pfizer estimated Ibrance could be an … Read More